Multicenter Phase II Study of FOLFOX/XELOX and Erbitux as First Line Therapy in Patients with Wild Type KRAS/BRAF Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2018
At a glance
- Drugs Cetuximab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms FLEET
- 02 Mar 2018 Pooled analysis of FLEET and FLEET2 studies has been presented in UMIN registry record (Unique ID issued by UMIN:UMIN000031233; Receipt No.: R000035663).
- 19 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
- 09 Jun 2012 Additional lead investigator(Mishima H) identified as reported by University Hospital Medical Information Network - Japan.